JP2015030689A5 - - Google Patents

Download PDF

Info

Publication number
JP2015030689A5
JP2015030689A5 JP2013160093A JP2013160093A JP2015030689A5 JP 2015030689 A5 JP2015030689 A5 JP 2015030689A5 JP 2013160093 A JP2013160093 A JP 2013160093A JP 2013160093 A JP2013160093 A JP 2013160093A JP 2015030689 A5 JP2015030689 A5 JP 2015030689A5
Authority
JP
Japan
Prior art keywords
resorcinol
external preparation
skin
total amount
ascorbic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013160093A
Other languages
Japanese (ja)
Other versions
JP6212320B2 (en
JP2015030689A (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2013160093A priority Critical patent/JP6212320B2/en
Priority claimed from JP2013160093A external-priority patent/JP6212320B2/en
Publication of JP2015030689A publication Critical patent/JP2015030689A/en
Publication of JP2015030689A5 publication Critical patent/JP2015030689A5/ja
Application granted granted Critical
Publication of JP6212320B2 publication Critical patent/JP6212320B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (8)

4−アルキルレゾルシノ−ル及び/又はそれらの塩を皮膚外用剤全量に対して0.001質量%〜5質量%と、アスコルビン酸、アスコルビン酸誘導体及びそれらの塩からなる群から選択される1種又は2種以上を皮膚外用剤全量に対して0.01質量%〜10質量%と、トラネキサム酸、トラネキサム酸誘導体及びそれらの塩からなる群から選択される1種又は2種以上を皮膚外用剤全量に対して0.01質量%〜10質量%とを含有する皮膚外用剤であって、
シュウ酸及びその塩並びにグルタチオンからなる群から選択される1種又は2種以上を含有することを特徴とする、皮膚外用剤。
4-alkyl-les sol Sino - selected from le and / or a 0.001% to 5% by weight salts thereof against the total amount of the skin treatment composition, ascorbic acid, the group consisting of ascorbic acid derivatives及originator these salts and 0.01% to 10% by weight of one or more against the total amount of the skin treatment composition is, one or selected from the group consisting of tranexamic acid, tranexamic acid derivative及originator these salts the above species met skin external preparation containing a 0.01 wt% to 10 wt% relative to the total amount of the skin treatment composition,
An external preparation for skin, comprising one or more selected from the group consisting of oxalic acid and salts thereof and glutathione.
前記シュウ酸及び/又はその塩を皮膚外用剤全量に対して0.01質量%〜2質量%含有することを特徴とする、請求項1に記載の皮膚外用剤。   The skin external preparation according to claim 1, wherein the oxalic acid and / or salt thereof is contained in an amount of 0.01% by mass to 2% by mass based on the total amount of the skin external preparation. 前記グルタチオンを皮膚外用剤全量に対して0.01質量%〜0.3質量%含有することを特徴とする、請求項1又は2に記載の皮膚外用剤。   The skin external preparation according to claim 1 or 2, wherein the glutathione is contained in an amount of 0.01 mass% to 0.3 mass% with respect to the total amount of the external preparation for skin. 前記4−アルキルレゾルシノールが、4−n−ブチルレゾルシノール、4−n−ヘキシルレゾルシノール、4−シクロペンチルレゾルシノール、4−シクロヘキシルレゾルシノール、4−(1−フェニル)エチルレゾルシノール、4−(2−フェニル)エチルレゾルシノール、4−イソオクチルレゾルシノール、4−アミルレゾルシノール、4−イソアミルレゾルシノール、4−イソブチルレゾルシノール、4−ターシャリーブチルレゾルシノール、4−(1−メチルプロピル)レゾルシノール、4−(1−メチルブチル)レゾルシノール、4−(1−エチルプロピル)レゾルシノール、4−(1−エチル−2−メチルプロピル)レゾルシノール、4−(1−イソプロピル−2−メチルプロピル)レゾルシノール、4−(1−ジメチル−3−メチルブチル)レゾルシノール、4−(1−ブチルペンチル)レゾルシノール、4−(1−イソブチル−3−メチルブチル)レゾルシノール及び4−イソステアリルレゾルシノールからなる群から選択される少なくとも一つであることを特徴とする、請求項1〜3の何れか一項に記載の組成物。 The 4-alkylresorcinol is 4-n-butylresorcinol, 4-n-hexylresorcinol, 4-cyclopentylresorcinol, 4-cyclohexylresorcinol, 4- (1-phenyl) ethylresorcinol, 4- (2-phenyl) ethylresorcinol 4-isooctyl resorcinol, 4-amyl resorcinol, 4-isoamyl resorcinol, 4-isobutyl resorcinol, 4-tertiary butyl resorcinol, 4- (1-methylpropyl) resorcinol, 4- (1-methylbutyl) resorcinol, 4- (1-ethylpropyl) resorcinol, 4- (1-ethyl-2-methylpropyl) resorcinol, 4- (1-isopropyl-2-methylpropyl) resorcinol, 4- (1-dimethyl-3- Chirubuchiru) resorcinol, characterized in that 4- (1-butylpentyl) resorcinol, is at least one selected from 4- (1-isobutyl-3-methylbutyl) group consisting of resorcinol and 4-isostearyl resorcinol, The composition as described in any one of Claims 1-3. 前記アスコルビン酸誘導体が、アスコルビン酸リン酸エステル又はアスコルビン酸−2−グルコシドであることを特徴とする、請求項1〜4の何れか一項に記載の皮膚外用剤。   The said ascorbic acid derivative is ascorbic acid phosphate ester or ascorbic acid-2-glucoside, The skin external preparation as described in any one of Claims 1-4 characterized by the above-mentioned. 前記トラネキサム酸誘導体が、トラネキサム酸のアルキルアミド、エステル、又は多量体であることを特徴とする、請求項1〜5の何れか一項に記載の皮膚外用剤。 The external preparation for skin according to any one of claims 1 to 5, wherein the tranexamic acid derivative is an alkylamide, ester, or multimer of tranexamic acid. 含水液状化粧料であることを特徴とする、請求項1〜6の何れか一項に記載の皮膚外用剤。   It is a water-containing liquid cosmetic, The skin external preparation as described in any one of Claims 1-6 characterized by the above-mentioned. 美白用化粧料であることを特徴とする、請求項1〜7の何れか一項に記載の皮膚外用剤。   It is a cosmetic for whitening, The skin external preparation as described in any one of Claims 1-7 characterized by the above-mentioned.
JP2013160093A 2013-08-01 2013-08-01 Topical skin preparation Active JP6212320B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013160093A JP6212320B2 (en) 2013-08-01 2013-08-01 Topical skin preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013160093A JP6212320B2 (en) 2013-08-01 2013-08-01 Topical skin preparation

Publications (3)

Publication Number Publication Date
JP2015030689A JP2015030689A (en) 2015-02-16
JP2015030689A5 true JP2015030689A5 (en) 2016-09-08
JP6212320B2 JP6212320B2 (en) 2017-10-11

Family

ID=52516319

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013160093A Active JP6212320B2 (en) 2013-08-01 2013-08-01 Topical skin preparation

Country Status (1)

Country Link
JP (1) JP6212320B2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108472203A (en) * 2015-11-30 2018-08-31 荷兰联合利华有限公司 Beauty mask
US11260005B2 (en) 2016-12-21 2022-03-01 Conopco, Inc. Personal care compositions with glutathione precursor comprising 4-substituted resorcinols and amino acids
CA3046138A1 (en) * 2016-12-21 2018-06-28 Unilever Plc Personal care compositions with glutathione precursor comprising nicotinamide and amino acids
EP3558244B1 (en) 2016-12-21 2022-02-23 Unilever IP Holdings B.V. Personal care compositions with cystine
WO2018113635A1 (en) 2016-12-21 2018-06-28 Unilever Plc Topical skin lightening additive and composition with amino acids and nicotinamide compounds
CA3046721A1 (en) 2016-12-21 2018-06-28 Unilever Plc Personal care compositions comprising poorly soluble compounds
EP3773422B1 (en) 2018-05-23 2021-11-10 Unilever IP Holdings B.V. Nanoemulsions and a method for making the same
WO2020262041A1 (en) * 2019-06-25 2020-12-30 ロート製薬株式会社 External composition containing ascorbic acid and/or salt thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2610626B1 (en) * 1987-02-09 1989-05-19 Oreal NOVEL ANTI-OXIDIZER SYSTEM BASED ON A STABILIZED ASCORBYL ESTER, COMPRISING AT LEAST ONE COMPLEXING AGENT AND AT LEAST ONE THIOL, AND COMPOSITIONS CONTAINING SUCH ANTI-OXIDIZING SYSTEM
KR960006859B1 (en) * 1992-03-06 1996-05-23 주식회사 태평양 Improved method for stability of ageing comprising thirosinase inhibitor activity
JP2000178134A (en) * 1998-12-16 2000-06-27 Kanae Kagawa:Kk Cosmetic agent for beautifying and whitening and its production
JP2009242321A (en) * 2008-03-31 2009-10-22 Shiseido Co Ltd Skin care preparation
JP2010189368A (en) * 2009-02-18 2010-09-02 Hiroyuki Iwasaki Liquid external preparation for skin
JP4646269B2 (en) * 2009-03-31 2011-03-09 株式会社資生堂 Skin preparation

Similar Documents

Publication Publication Date Title
JP2015030689A5 (en)
CA2894892A1 (en) Boronic acid derivatives and therapeutic uses thereof
JP2015078230A5 (en)
EA201692301A1 (en) DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION
MX2015008628A (en) Boronic acid derivatives and therapeutic uses thereof.
RU2016124331A (en) ORGANIC CARE COMPOSITION
AR094918A1 (en) TETRAHYDROPIRROLOTIAZINE COMPOUNDS AS BACE INHIBITORS
JP2016536458A5 (en)
RU2015141285A (en) Antiperspirant Compositions
RU2017133244A (en) COMPOSITIONS CONTAINING COMBINATIONS OF ORGANIC ACIDS
JP2012533614A5 (en)
CA2922375C (en) Alpha-tea salt forms: compositions and uses for treating disease
CL2014003607A1 (en) Compounds derived from benzodioxol, acetylcholinesterase inhibitors; Preparation method; intermediary compounds; pharmaceutical composition; and use in the prevention or treatment of Alzheimer's disease.
JP2015157874A5 (en)
JP2013253067A5 (en)
MX2016005339A (en) Anti-perspirant composition.
EA201791670A1 (en) HARD COMPOSITIONS FOR CARE OF THE ORAL CAVITY
JP2012526881A5 (en)
RU2013110517A (en) MEANS FOR PREVENTION OR TREATMENT OF NON-ALCOHOLIC STEATHEPATITIS
JP2019504843A5 (en)
RU2016123374A (en) METAL BIOCORROSION INHIBITOR
EA201890018A1 (en) COMPOSITION FOR ATTACHING HAIR FORM
RU2015153704A (en) Antiperspirant composition
JP2016029099A5 (en) Cosmetics and antibacterial method thereof
JP2014526571A5 (en)